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Nod2 has been extensively characterized as a bac-
terial sensor that induces an antimicrobial and in-
flammatory gene expression program. Therefore, it
is unclear why Nod2 mutations that disrupt bacterial
recognition are paradoxically among the highest
risk factors for Crohn’s disease, which involves an
exaggerated immune response directed at intestinal
bacteria. Here, we identified several abnormalities
in the small-intestinal epithelium of Nod2/ mice
including inflammatory gene expression and goblet
cell dysfunction, which were associated with excess
interferon-g production by intraepithelial lympho-
cytes and Myd88 activity. Remarkably, these ab-
normalities were dependent on the expansion of a
common member of the intestinal microbiota Bac-
teroides vulgatus, which also mediated exacerbated
inflammation in Nod2/ mice upon small-intestinal
injury. These results indicate that Nod2 prevents in-
flammatory pathologies by controlling themicrobiota
and support a multihit disease model involving spe-
cific gene-microbe interactions.
INTRODUCTION
The surfaces of the body, particularly the gastrointestinal tract,
are exposed to a large number of diverse microbes that are
collectively referred to as the microbiota. Individual members
of the microbiota are generally referred to as commensals
because their presence inmost individuals is innocuous or bene-
ficial. However, a breakdown in tolerance toward thesemicrobes
is considered central to the origin of Crohn’s disease (CD), a ma-
jor type of inflammatory bowel disease (IBD) characterized by
excessive inflammatory cytokine production by T cells and dam-
age to the intestinal epithelium (Abraham and Cho, 2009). IBD
patients typically display imbalances in the composition of the
microbiota, and reducing exposure to intestinal bacteria has
been shown to ameliorate recurrent inflammation (Packey and
Sartor, 2009). Additionally, genetic susceptibility factors thathave been identified are involved in host-microbe interactions,
as exemplified by mutations in NOD2 (Jostins et al., 2012).
Nod2 is a cytosolic bacterial sensor that induces cytokine and
antimicrobial gene expression in response to the peptidoglycan
constituent muramyl dipeptide (Girardin et al., 2003; Inohara
et al., 2003). Therefore, Nod2 function may be key to under-
standing how equilibrium between the immune system and
commensal bacteria is maintained.
The threemajor mutations in the gene encoding NOD2 that are
associated with CD have been extensively demonstrated to
reduce or ablate the ability to sense bacterial products in cell cul-
ture assays (Billmann-Born et al., 2011; Chamaillard et al., 2003),
primary cells from humans (Cooney et al., 2010; Netea et al.,
2005; Travassos et al., 2010), and mouse models in vivo (Kim
et al., 2011; Watanabe et al., 2008). Therefore, Nod2/ mice
have been widely used to investigate the basic immune function
of this gene as well as its association with CD. Despite progress
in understanding Nod2 function during infectious disease set-
tings, the effect of Nod2 deletion on the immune response to
the intestinal microbiota remains unclear. Nod2/ mice on a
mixed genetic background were initially demonstrated to display
reduced expression of antimicrobial defensins by Paneth cells,
an epithelial cell type in the small-intestinal crypt that generates
antimicrobial granules (Kobayashi et al., 2005). However, a sub-
sequent study did not observe decreases in defensin expression
in Nod2/ mice backcrossed to the C57BL/6 (B6) background
(Shanahan et al., 2014). In other studies examining the composi-
tion of the intestinal microbiota, both Nod2/ mice and CD
patients with NOD2mutation were shown to have an overrepre-
sentation of the Bacteroides genus (Couturier-Maillard et al.,
2013;Mondot et al., 2012; Petnicki-Ocwieja et al., 2009; Rehman
et al., 2011). In spite of this concordance between mice and hu-
mans, cohousing Nod2/ and control mice eliminated differ-
ences in the composition of commensal bacteria, suggesting
that the expansion of Bacteroides is nonspecific (Robertson
et al., 2013). Because mutation of NOD2 remains one of the
strongest CD risk factors and associates with small-intestinal
involvement, we sought to resolve these issues by examining
the small-intestinal abnormalities present in Nod2/ mice.
Here, we find that Nod2/ mice display abnormalities in the
small-intestinal epithelium including defects inmucusproduction
by goblet cells. These epithelial abnormalities were associated
with an increase in interferon-g (IFN-g)-expressing intraepithelialImmunity 41, 311–324, August 21, 2014 ª2014 Elsevier Inc. 311
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Nod2 Prevents Commensal-Mediated Inflammationlymphocytes (IELs) and were dependent on the innate immune
signaling molecule Myd88. Remarkably, these intestinal abnor-
malities were dependent on the expansion of the commensal
bacterium Bacteroides vulgatus. Finally, we demonstrate that
B. vulgatus mediated exacerbated small-intestinal inflamma-
tion in Nod2/ mice after nonsteroidal anti-inflammatory drug
(NSAID) treatment. Taken together, we have identified a role for
Nod2 in preventing inflammation by restricting the pathological
expansion of a common member of the intestinal microbiota.
RESULTS
Nod2–/– Mice Display Inflammatory Gene Expression in
the Small-Intestinal Epithelium
The following precautions have been taken because previous
studies have revealed that differences in background and hous-
ing conditions are confounding variables for investigating Nod2
function. (1) All mutant mice have been backcrossed to the B6
background. (2) Mice were maintained in a barrier facility where
they were routinely checked for the absence of specific infec-
tious agents including murine norovirus (MNV), Helicobacter,
and segmented filamentous bacteria (SFB). (3) Mutant mice
were compared to wild-type (WT) B6 control mice bred onsite
in the same facility. (4) Mutant mice were maintained since birth
in separate cages from WT mice in the initial set of experiments,
and cohousing experiments were performed later in the study
where indicated.
We previously reported that mice deficient in another CD-sus-
ceptibility gene,Atg16L1, develop Paneth cell granule abnormal-
ities in a manner dependent on murine norovirus (MNV) infection
(Cadwell et al., 2010). Because the role of Nod2 in Paneth cells is
still uncertain, we examined Paneth cell morphology in Nod2/
mice by light microscopy and lysozyme immunofluorescence (IF)
in the presence and absence of MNV. In contrast to MNV-in-
fected Atg16L1 mutant mice, Nod2/ and WT mice did not
display aberrant Paneth cell morphology by light microscopy
even after MNV infection (Figures S1A–S1D). Similarly, only
mild abnormalities in lysozyme distribution were detected in
the Nod2/ samples, independently of MNV (Figures S1A–
S1D). These results are consistent with observations made in
CD patients, where individuals with the ATG16L1 risk allele
display a more severe alteration in lysozyme distribution
compared to patients with NOD2 risk alleles (Cadwell et al.,
2008; Vandussen et al., 2014).
Because Nod2 was suggested to mediate antimicrobial gene
expression by Paneth cells, we performed a microarray analysis
on laser-captured epithelial cells from the crypt base where Pan-
eth cells are located. Unexpectedly, pathway analysis indicated
that Nod2/ samples were enriched, rather than deficient, in
transcripts associated with inflammation, fatty acid biosynthesis
(eicosanoid pathway), and host defense (Figures 1A, 1B, and
S1E; Table S1). Gene set enrichment analysis (GSEA) confirmed
thatNod2/mice displayed a proinflammatory gene expression
signature in the epithelium. Many of the genes with the highest
differential expression encode antimicrobial molecules such
as Reg3b, Relm-b, Pla2, and Defb1 (Figure S1F). We validated
these results by staining small-intestinal sections for Reg3b
because a human homolog has been shown to display increased
expression in IBD patients (Ogawa et al., 2003). Compared to the312 Immunity 41, 311–324, August 21, 2014 ª2014 Elsevier Inc.minimal staining observed inWTmice, high levels of Reg3bwere
detected in the Nod2/ crypt epithelium that extended partway
up the length of the villi (Figures 1C, 1D, S1G, and S1H). Relm-b,
which has been shown to mediate inflammation (McVay et al.,
2006), was also highly expressed in Nod2/ small-intestinal
sections compared to WT (Figures 1D, S1I, and S1J). Over-
production of Reg3b and Relm-b is most likely due to a response
to bacteria because treatment with an antibiotic cocktail
reduced expression to WT levels (Figures 1C–1E). Increased
Reg3b and Relm-b staining was not observed in the colon, and
unlike the small intestine, colonic Relm-b levels increased with
antibiotics as previously described (Figures S1I and S1K; Hill
et al., 2010). Thus, Nod2 deficiency leads to a proinflammatory
gene expression signature specifically in the small-intestinal
epithelium.
Nod2 Is Required to Maintain Small-Intestinal Goblet
Cell Function
We next investigated the possibility that Nod2/ mice develop
other abnormalities in the small-intestinal epithelium. Mucus
secreted by goblet cells forms a physical barrier that separates
intestinal bacteria from the epithelium. Goblet cells in IBD pa-
tients have decreased Muc2 expression, and mice deficient in
this dominant intestinal mucin display increased expression of
antimicrobial genes including Reg3b (Burger-van Paassen
et al., 2012; Sheng et al., 2012). Consistent with these observa-
tions, we observed decreased Muc2 expression in the small
intestine of Nod2/ mice compared to WT mice (Figure 2A). IF
analysis also indicated that there was a decrease in the number
of cells in the villi that stained positive for Muc2 and a corre-
sponding decrease in the amount of Muc2 in the lumen between
villi (Figures 2B and 2C). Additionally, light microscopy analysis
of PAS-Alcian blue-stained sections confirmed the reduction
and staining intensity of goblet cells in the villi of Nod2/ mice
(Figures 2D–2G). Transmission electron microscopy (TEM) re-
vealed that Nod2/ mice had many fewer mucin granules per
goblet cell, and many of these granules had an abnormal fused
appearance that was rarely detected in WT samples (Figures
2H, 2I, S2A, and S2B). Thus, Nod2 has an unappreciated func-
tion in maintaining the goblet cell compartment.
Goblet Cell Abnormalities Are Associated with an
Increased Proportion of IFN-g-Expressing Lymphocytes
IFN-g production by lymphocytes has been suggested to
contribute to the development of intestinal pathologies observed
in CD patients (Abraham and Cho, 2009). A previous observation
indicating thatNod2/mice have an increase in IFN-g+ lympho-
cytes in Peyer’s patches and mesenteric lymph nodes (MLNs)
(Barreau et al., 2010) has been shown to be downstream of Hel-
icobacter infection (Biswas et al., 2010). Although our mice are
maintained in a Helicobacter-negative environment, we consid-
ered the possibility that cytokine production by intraepithelial
lymphocytes (IELs) would be preferentially affected in Nod2/
mice due to the proximity of these cells to the intestinal epithe-
lium and lumenal bacteria. Nod2/ mice were recently shown
to have a reduction in the number of IELs (Jiang et al., 2013),
an observation that we confirmed (Figure 3A). However, we
found that a higher proportion of the IELs fromNod2/mice ex-
pressed IFN-g compared to control mice, which included both
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Figure 1. Nod2–/– Mice Display Inflammatory Gene Expression in the Small-Intestinal Epithelium
(A) Microarray analysis of transcripts displaying >1.25-fold enrichment in crypt-base epithelial cells from Nod2/ compared to WT mice. Gene ontology (GO)
terms with the highest significance are shown.
(B) Functional clusters displaying greatest enrichment from (A). n = 3 mice per genotype.
(C) Immunofluorescence (IF) staining of Reg3b in WT andNod2/ small-intestinal sections with and without treatment with antibiotics (metronidazole, ampicillin,
vancomycin, neomycin). Scale bar represents 100 mm.
(D) Quantification of the mean fluorescence intensity (MFI) of Reg3b in small-intestinal sections as in (C). nR 5 mice per genotype.
(E) Quantification of MFI of Relm-b in WT and Nod2/ small-intestinal sections with and without antibiotics treatment. nR 3 mice per genotype.
****p < 0.0001 by ANOVA with Holm-Sidak multiple comparisons test for (D) and (E). Data are represented as mean ± SEM from at least two independent
experiments in (D) and (E). See also Figure S1.
Immunity
Nod2 Prevents Commensal-Mediated InflammationCD8+ and TCRgd+ T cell subsets (Figures 3B–3D). In contrast, we
did not detect differences in the amount of IFN-g+ lymphocytes
in the small-intestinal and colonic lamina propria (LP), MLNs,
or Peyer’s patches when comparing WT and Nod2/ mice
(Figures S3A and S3B).
To assess the role of lymphocytes in the goblet cell defects,
we crossed Nod2/ mice with lymphocyte-deficient Rag1/
mice. We found that double mutant Nod2/Rag/ mice had
goblet cells with normal morphology and a similar number of
goblet cells per villi compared to single mutant Rag/ mice
(Figures 3E and 3F). In contrast, Reg3b levels remained high
in Nod2/Rag/ mice (Figure S3C). Thus, defects in goblet
cells, but not necessarily antimicrobial gene expression, are
dependent on the presence of lymphocytes. Additionally, treat-
ment of Nod2/ mice with an anti-IFN-g-depleting antibody,
but not isotype control, led to full restoration of goblet cellmorphology and numbers (Figures 3G and 3H). Thus, goblet
cell abnormalities in Nod2/ mice are dependent on lympho-
cytes and IFN-g.
Small-Intestinal Abnormalities Are Downstream of
Myd88 Signaling
Nod2-mediated gene expression is dependent on the adaptor
and kinase Rip2, although Rip2-independent functions of Nod2
in inflammasome and autophagy activation have been described
(Hsu et al., 2008; Travassos et al., 2010). We examined Rip2/
mice for intestinal abnormalities to determine whether the above
observations reflect a Rip2-dependent function of Nod2.Rip2/
mice displayed a similar increase in Reg3b expression in small-
intestinal sections as Nod2/ mice (Figure 4A). Also, Rip2/
mice had a substantial decrease in the number of goblet cells
per villi, and the cells displayed aberrant morphology (FiguresImmunity 41, 311–324, August 21, 2014 ª2014 Elsevier Inc. 313
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Figure 2. Nod2–/– Mice Display Goblet Cell Abnormalities in the Small Intestine
(A) qPCR analysis of Muc2 expression normalized to Gapdh in small-intestinal tissue harvested from WT and Nod2/ mice.
(B) IF staining of Muc2 in small-intestinal sections. Muc2-positive cells and extracellular staining are denoted by white arrowheads and asterisks, respectively.
(C) Number of Muc2+ cells per villi from (B).
(D) PAS-Alcian blue staining of small-intestinal sections from WT and Nod2/ mice. Red arrows denote goblet cells.
(E–G) Quantification of the number of goblet cells per villi (E), the proportion displaying translucent staining or atypical morphology (F), and number of goblet cells
displaying normal morphology per villi (G) from the PAS-Alcian blue-stained sections in (B).
(H) Transmission electron microscopy analysis of goblet cell morphology in WT and Nod2/ small intestine. Red arrowheads denote individual granules.
(I) Quantification of the number of mucin granules per goblet cell in (H), performed by manually counting individual granules per cell in at least 25 cells per mouse.
nR 3 mice per genotype.
**p < 0.01, ***p < 0.001, and ****p < 0.0001 by unpaired two-tailed t test in (A), (C), (E)–(G), and (I). Scale bars represent 100 mm in (B) and (D) and 2 mm in (H). All bar
graphs display mean ± SEM from at least two independent experiments. Bars and numbers represent the mean in (E). See also Figure S2.
Immunity
Nod2 Prevents Commensal-Mediated Inflammation4B and 4C). In contrast, Atg16L1 mutants did not display these
abnormalities (Figures S4B–S4F). Consistent with a relationship
between goblet cell abnormalities and IFN-g production by lym-
phocytes, Rip2 deficiency also led to an increase in the propor-314 Immunity 41, 311–324, August 21, 2014 ª2014 Elsevier Inc.tion of IFN-g+ IELs (Figure 4D). Thus, Rip2/ and Nod2/ mice
display similar small-intestinal abnormalities.
The toll-like receptor (TLR) adaptor molecule Myd88
functions in the small-intestinal epithelium to regulate the
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Figure 3. Nod2–/– Mice Have an Increased Proportion of IFN-g-Expressing Intraepithelial Lymphocytes
(A) Total number of intraepithelial lymphocytes (IELs) harvested from WT and Nod2/ mice. nR 16 mice per genotype.
(B) Representative flow cytometry plot of CD8+ IELs from (A) stained for intracellular IFN-g and IL-17 expression after stimulation with PMA and ionomycin gated
on CD3+ live cells.
(C and D) Quantification of the proportion of CD8+ (C) and TCRd+ (D) IELs expressing IFN-g from (B). nR 6 mice per genotype.
(E and F) Quantification of the number of goblet cells per villi (E) and the proportion displaying abnormal morphology (F) from PAS-Alcian blue-stained small-
intestinal sections in Rag/ and Nod2/Rag/ mice. nR 3 mice per genotype.
(G and H) Quantification of the number of goblet cells per villi (G) and the proportion displaying abnormal morphology (H) from PAS-Alcian blue-stained small-
intestinal sections in WT and Nod2/ mice treated with antibody to IFN-g or isotype control. nR 3 mice per genotype.
*p < 0.05, **p < 0.01, and ****p < 0.0001 by unpaired two-tailed t test in (A), (C), and (D), and ANOVA with Holm-Sidak multiple comparisons test for (G) and (H). All
bar graphs display mean ± SEM from at least two independent experiments. Bars and numbers represent the mean in (E) and (G). See also Figure S3.
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Nod2 Prevents Commensal-Mediated Inflammationexpression of antimicrobial molecules including those that we
identified as increased in Nod2/ mice such as Reg3b and
Relm-b (Vaishnava et al., 2008). Also, Nod2 deficiency has
been suggested to lead to unrestricted TLR signaling (Wata-
nabe et al., 2004, 2008). Although Myd88 is typically necessary
for maintaining the epithelial barrier, Myd88 deletion protects
against epithelial damage in certain models of intestinal inflam-
mation (Asquith et al., 2010; Hoshi et al., 2012; Raetz et al.,
2013). To examine the role of Myd88 in the generation of the
above small-intestinal abnormalities, we generated double
mutant Nod2/Myd88/ mice and found that the abnormal-
ities were eliminated. Nod2/Myd88/ mice did not display
increases in Reg3b or aberrant goblet cell morphology, and
the number of goblet cells were restored (Figures 4E–4G).
The proportion of IFN-g+ IELs was also reduced to WT levels
(Figure 4H). These results indicate that the absence of Nod2function induces small-intestinal abnormalities in a manner
dependent on MyD88.
Nod2 Prevents Expansion of Bacteroides vulgatus
Our finding that the treatment of Nod2/ mice with a combina-
tion of antibiotics reduces the expression of Reg3b and Relm-b
(Figures 1C and 1D) implicates commensal bacteria in the gener-
ation of intestinal abnormalities. To compare the composition
of the intestinal microbiota, we performed deep sequencing of
16S rRNA gene amplicons from stool harvested from WT and
Nod2/ mice maintained in separate cages as in previous ex-
periments. Principle coordinate analysis (PCoA) revealed that
bacterial community structures were significantly different be-
tween WT and Nod2/ mice (Figure 5A). Similar to previous
studies in which Nod2/ and control mice were maintained in
separate cages, we found a striking overrepresentation of theImmunity 41, 311–324, August 21, 2014 ª2014 Elsevier Inc. 315
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Figure 4. Intestinal Abnormalities in Nod2–/– Mice Are Observed in Rip2–/– Mice and Dependent on Myd88
(A–D) Quantification of Reg3b IF staining (A), number of goblet cells per villi (B) and proportion displaying abnormal morphology by light microscopy (C), and the
proportion of IFN-g+ IELs by flow cytometry (D) in the small intestine of WT and Rip2/ mice.
(E) Representative IF staining of Reg3b in Nod2/ and Nod2/MyD88/ small-intestinal sections. Scale bar represents 100 mm.
(F) Quantification of Reg3b IF in WT, Nod2/, MyD88/, and Nod2/MyD88/ small intestine.
(G) Quantification of the number of goblet cells per villi in WT, Nod2/, MyD88/, and Nod2/MyD88/ small intestine.
(H) Flow cytometry analysis of the proportion of IFN-g+ IELs in WT, Nod2/, MyD88/, and Nod2/MyD88/ mice.
nR 3mice per genotype, **p < 0.01 and ****p < 0.0001 by unpaired two-tailed t test in (A)–(D) and ANOVAwith a Holm-Sidakmultiple comparisons test for (F)–(H).
All bar graphs display mean ± SEM from at least two independent experiments. Bars and numbers represent the mean in (B) and (G). See also Figure S4.
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Nod2 Prevents Commensal-Mediated InflammationBacteroides genus in Nod2/mice, which we further confirmed
by qPCR (Figures 5B, 5C, and S5B). When we plated stool on
agar selective for Bacteroides under anaerobic conditions, we
observed that colonies of a uniform morphology consistently
grew out from Nod2/ samples but not from WT (Figures 5D
and S5C). Sequencing of the entire 16S rRNA gene revealed a
100% match with Bacteroides vulgatus. Additional sequencing
analysis of 15 colonies (3 each from 5 different Nod2/ mice)
confirmed that they were all B. vulgatus, and we did not detect
any other species on these plates. Examination by fluorescent
in situ hybridization (FISH) also indicated that B. vulgatus was
present throughout the gastrointestinal tract of Nod2/ mice
and undetectable in controls (Figure S5A). In contrast, we occa-
sionally detected other Bacteroides species in WT mice that
were not detected in Nod2/ mice (Figure S5C).
It is possible that only Nod2/ mice were exposed to
B. vulgatus in a previous generation and remained colonized316 Immunity 41, 311–324, August 21, 2014 ª2014 Elsevier Inc.through vertical transmission, thus leading to a ‘‘legacy effect.’’
It is unlikely that vertical transmission alone accounts for coloni-
zation of Nod2/ mice because Rip2/ mice also displayed
high amounts of B. vulgatus in the stool, and this bacterium
was not recovered from other mouse lines such as Atg16L1mu-
tants (Figures 5E and S4A). To further rule out a legacy effect, we
intentionally exposed WT mice to the microbiota of Nod2/
mice. As with the previous study in which mice were cohoused
(Robertson et al., 2013), we found that WT mice placed in the
same cage with Nod2/ mice became readily colonized with
B. vulgatus. However, upon reseparation, B. vulgatus decreased
to an undetectable level over time in WTmice, but remained sta-
ble in Nod2/ mice (Figure 5F). These results indicate that WT
mice require continual exposure to remain colonized, whereas
B. vulgatus levels are stable in Nod2/ mice and can be trans-
mitted to the next generation. In addition, mice heterozygous for
Nod2 deletion displayed levels of B. vulgatus colonization and
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Figure 5. Nod2 Prevents the Expansion of Bacteroides vulgatus
(A) PCoA plot generated from unweighted UniFrac distance matrix displaying the distinct clustering pattern of intestinal microbial communities in WT and
Nod2/ mice.
(B) Relative abundances of taxonomic groups averaged across WT and Nod2/ mice.
(C) Quantification of Bacteroides genus-specific 16S rRNA gene detected by qPCR normalized to total bacterial 16S in stool of WT and Nod2/ mice.
(D) Quantification of colony forming units (cfu) of anaerobic bacteria identified as Bacteroides vulgatus from stool of WT and Nod2/ mice plated on BBE agar.
n = 10 mice per genotype.
(E) Quantification of B. vulgatus in stool of WT and Rip2/ mice. n = 5 mice per genotype.
(F) Quantification of B. vulgatus in stool of WT and Nod2/ mice that were cohoused and separated by genotype on day 0. n = 5 mice per genotype.
(G) Quantification of B. vulgatus in stool of WT, Nod2/, MyD88/, and Nod2/MyD88/ mice. nR 3 mice per genotype.
(H) Quantification ofB. vulgatus in stool harvested from bonemarrow chimeras generated fromWT andNod2/mice that were cohoused and then separated by
genotype.
(legend continued on next page)
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Nod2/ mice (Figures S4G–S4K). This gene-dosage effect
strongly argues that our observations are due toNod2 deficiency
rather than being an artifact of housing conditions. Finally, we
did not detect B. vulgatus colonization in Myd88/ mice, but
Nod2/Myd88/ mice remained highly colonized (Figure 5G).
These results highlight a specific relationship between defi-
ciency in the Nod2/Rip2 pathway and Bacteroides overgrowth.
Nod2 is highly expressed in myeloid and dendritic cell line-
ages, but it can also be detected in epithelial cell types (Kobaya-
shi et al., 2005). To differentiate between the function of Nod2 in
these compartments, we generated bone marrow chimeras
using WT and Nod2/ mice as both donors and recipients
(Figure S5F). Chimeric mice of different origins were cohoused
with each other for 4 weeks to allow equal colonization by
B. vulgatus (day 0 in Figure 5H), and bacterial burden was then
measured after separating mice by genotype. We found that
B. vulgatus levels steadily decreased over time in WT and
Nod2/ mice that received WT bone marrow (Figure 5H). In
contrast, WT and Nod2/ mice that received Nod2/ bone
marrow continued to shed high amounts of B. vulgatus (Fig-
ure 5H). Thus, Nod2 deficiency in the hematopoietic compart-
ment confers susceptibility to B. vulgatus. Importantly, this
experiment definitively rules out a legacy effect because the ge-
notype of the donor rather than the recipient mouse determined
B. vulgatus colonization.
B. vulgatus Mediates Intestinal Abnormalities and
Inflammation in Nod2–/– Mice
In the above chimericmice, we found thatWTmice reconstituted
with Nod2/ bone marrow developed goblet cell abnormalities,
whereas Nod2/ mice that received WT bone marrow were
‘‘cured’’ of this defect (Figures S5C–S5E). Thus, epithelial abnor-
malities appear to be linked to B. vulgatus levels. To further
assess the functional consequence of B. vulgatus colonization
in Nod2/ mice, we treated mice with metronidazole, an antibi-
otic that targets anaerobic bacteria. 16S deep sequencing
and plating on selective media confirmed that metronidazole
treatment eliminated the Bacteroides overgrowth observed in
Nod2/ mice (Figures 6A, 6B, and S6A). Nod2/ mice that
received metronidazole displayed decreased epithelial Reg3b
levels, restoration of normal goblet cell numbers and
morphology, and reduced frequency of IFN-g+ IELs (Figures
6C–6G). In contrast, vancomycin treatment, which targets
Gram-positive bacteria, did not deplete B. vulgatus and did not
reverse intestinal abnormalities (Figures 6H–6K and S6D).
Next, we reintroduced B. vulgatus by orally gavaging metroni-
dazole-treated WT and Nod2/mice with 13 108 colony-form-
ing units (CFU) of the cultured bacteria or an equivalent amount
of heat-killed bacteria. Only Nod2/ mice that received live
B. vulgatus displayed abnormalities in Reg3b expression, goblet
cells, and IFN-g+ IELs (Figures 6L–6N). Interestingly, metronida-
zole pretreatment allowed WT mice to be transiently colonized
by B. vulgatus during the 2 week time frame of this experiment,Black asterisks refer toWT/WTcompared to KO/WTand red asterisks refer to
to limit of detection. nR 5 mice per genotype. *p < 0.05, **p < 0.01, ***p < 0.001, a
test in (D), (E), and (G), and Kruskal-Wallis with Dunn’s multiple comparisons test in
the mean in (D) and (E). See also Figure S5.
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in a WT host even when exposure is forced (Figure S6B). The in-
testinal abnormalities may require the ability of this bacterium
to access regions proximal to the epithelium because a sub-
stantially higher amount of tissue-associated B. vulgatus was
recovered from Nod2/ mice under these same conditions
(Figure S6C). To test whether these observations are specific
to B. vulgatus, we inoculated metronidazole-treated WT and
Nod2/ mice with Bacteroides thetaiotaomicron VPI-5482, a
commensal strain that is frequently used to investigate host
responses in mouse models (Goodman et al., 2009; Hooper
et al., 2001; Peterson et al., 2007). Neither WT nor Nod2/
mice developed small-intestinal abnormalities in response to
B. thetaiotaomicron on day 3 or 12 postinoculation despite
detection of a high amount of bacteria in the stool (Figures
S6E–S6L). Another genus member, Bacteroides uniformis, was
able to stably colonize metronidazole-treated WT mice but not
Nod2/mice (Figure S6M). Also, we were able to detectBacter-
oides acidophilus, Bacteroides eggerthii, and Parabacteroides
goldsteinii in WT mice but not in Nod2/ mice (Figure S5C).
These observations suggest that efficiency or location of coloni-
zation may have an important role in determining whether a
given Bacteroides species can induce intestinal abnormalities
in Nod2/ mice.
To relate these findings to IBD, we analyzed the role of
B. vulgatus in Nod2/ mice treated with piroxicam, a NSAID
that can induce small-intestinal injury (Han et al., 2009).
Compared to similarly treated WT mice, Nod2/ mice receiving
piroxicam displayed increases in focal ulceration, epithelial hy-
perplasia, and peri-cryptal and submucosal infiltrates (Figures
7A and 7B). Moreover, we found that only Nod2/ mice dis-
played blood in the small-intestinal lumen and attachment of
the wall of the ileal-cecal junction to the surrounding tissue
of the peritoneal cavity (Figures S7A and S7B). Piroxicam did
not induce these pathologies in Nod2/ mice that received
metronidazole (Figures 7B and S7B). In contrast, inoculation of
metronidazole-treated Nod2/ mice with B. vulgatus prior to
piroxicam treatment restored the appearance of the pathologies
described above (Figures 7B and S7B). Consistent with a rela-
tionship between intestinal bacteria and exacerbated disease,
16S deep sequencing revealed that the difference in the micro-
biota between WT and Nod2/ mice was magnified after pirox-
icam treatment (Figure 7C). The composition of the intestinal
microbiota in Nod2/ mice shifted away from the initial
B. vulgatus-dominated flora toward a typical ‘‘dysbiotic’’ flora
with decreased diversity and phylum-level changes (Figures 7D
and 7E). In general, the effect of piroxicam on the microbiota
was exaggerated in Nod2/ mice compared to WT mice and
included increases in Proteobacteria and decreases in Bacter-
oidetes and Clostridiales (Figures 7C, 7E, and S7C). These
changes are similar to those recently described in early-onset
CD patients (Gevers et al., 2014). Thus, B. vulgatus is essential
for at least initiating intestinal inflammation in Nod2/ mice
after piroxicam treatment, which induces additional large-scaleWT/WTcompared to KO/KO. N.D. indicates not detected; dotted line refers
nd ****p < 0.0001 by unpaired two-tailed t test in (C), Wilcoxon-Mann-Whitney
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Figure 6. B. vulgatus Mediates Small-Intestinal Abnormalities in Nod2–/– Mice
(A) Relative abundances of intestinal microbial communities in WT and Nod2/ mice before and after metronidazole treatment.
(B) Quantification of B. vulgatus in stool of WT and Nod2/ mice after 0, 5, and 10 days of metronidazole treatment.
(C–G) Quantification of IF staining of Reg3b (C) and Relm-b (D), number of goblet cells per villi (E) and the proportion displaying abnormal morphology (F) by light
microscopy, and IFN-g+ IELs by flow cytometry in WT and Nod2/ mice treated with metronidazole (G).
(H–K) Quantification of IF staining of Reg3b (H) and Relm-b (I), and number of goblet cells per villi (J) and the proportion displaying abnormal morphology (K) by
light microscopy in WT and Nod2/ mice treated with vancomycin.
(L–N) Quantification of IF staining of Reg3b (L), proportion of goblet cells displaying abnormal morphology by light microscopy (M), and IFN-g+ IELs by flow
cytometry in WT and Nod2/ mice treated with metronidazole and gavaged with 108 cfu B. vulgatus or equivalent amount of heat-killed bacteria (N).
Dotted line denotes limit of detection. nR 3 mice per genotype in (A)–(K), n = 9–10 mice per genotype in (L)–(N). *p < 0.05, **p < 0.01, ***p < 0.001, and ****p <
0.0001 by Kruskal-Wallis with Dunn’s multiple comparisons test for (B), unpaired two tailed t test in (C)–(K), and ANOVA with a Holm-Sidak multiple comparisons
test for (L)–(N). Data are represented asmean ± SEM from at least two independent experiments in (B)–(D) and (F)–(N). Bars and numbers represent themean in (E)
and (J). See also Figure S6.
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Figure 7. Nod2–/– Mice Are Susceptible to Piroxicam-Induced Small-Intestinal Inflammation in the Presence of B. vulgatus
(A) Representative H&E-stained small-intestinal sections from piroxicam-treated WT and Nod2/ mice. Black arrow and asterisk point to a focal ulcer and
epithelial hyperplasia, respectively. Scale bar represents 200 mm.
(B) Quantification of small-intestinal pathology in WT and Nod2/ (KO) mice treated with piroxicam.
(C) Graph represents a PCoA plot generated from unweighted UniFrac distance matrices of WT andNod2/mice before and after piroxicam treatment, overlaid
with the distribution of different bacterial taxa based on phylogenetic information.
(D) Quantification of the number of observed taxonomic units (OTUs) in WT and Nod2/ mice before and after piroxicam treatment.
(E) Relative abundances of intestinal microbial communities in WT and Nod2/ mice before and after piroxicam treatment.
n = 4–5 mice per group. *p < 0.05, **p < 0.01, and ns = not significant by ANOVA with Holm-Sidak multiple comparisons test for (B). Data are represented as
mean ± SEM in (B) and (D).
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contributes to the ensuing pathologies.
DISCUSSION
Despite the discovery of NOD2 as a susceptibility gene more
than a decade ago, it is still unclear why mutations that disrupt
the ability of Nod2 to mediate an immune response to bacteria
would increase the risk of developing CD, which is a disease
characterized by an excessive immune response to intestinal320 Immunity 41, 311–324, August 21, 2014 ª2014 Elsevier Inc.bacteria. Addressing this question has been hindered by the
lack of spontaneous inflammatory abnormalities reported in
Nod2/mice. This problem has been compounded by inconsis-
tent observations by individual laboratories due to differences in
the background, housing conditions, and health status of the
mice. In this study, we identified several inflammatory abnormal-
ities in the small intestine of Nod2/ mice: antimicrobial gene
expression, goblet cell defects, and an increase in the proportion
of IFN-g-expressing IELs. All three of these abnormalities, as
well as increased inflammation induced by piroxicam, were
Immunity
Nod2 Prevents Commensal-Mediated Inflammationassociated with the susceptibility of Nod2/mice to B. vulgatus
expansion and stable colonization. Thus, our results indicate that
Nod2 prevents harmful immune responses by controlling the
expansion of a proinflammatory member of the microbiota.
Recent studies indicate that defective cytokine production
by myeloid or dendritic cells in response to bacteria leads to
impaired immunity in Nod2/ mice (Davis et al., 2011; Jiang
et al., 2013). Our finding that Nod2 deficiency in the hematopoi-
etic compartment is primarily responsible for uncontrolled
B. vulgatus colonization could reflect such a role for Nod2. For
instance, the inability ofNod2/ dendritic cells to produce cyto-
kines such as IL-15 that support lymphoid cells (Jiang et al.,
2013) provides a potential explanation for the initial susceptibility
to B. vulgatus. Although the exact antimicrobial response neces-
sary for resistance to B. vulgatus requires further elucidation,
our results are consistent with a model in which unrestricted
B. vulgatus expansion evokes a subclinical inflammatory
response including IFN-g production that drives goblet cell ab-
normalities and is further exacerbated by piroxicam-induced
inflammation (Figure S7D).
The intestinal abnormalities in Nod2/ mice we describe are
probably relevant to CD. The increased expression of Reg3 fam-
ily members and defective Muc2 production by goblet cells has
been documented in patients (Ogawa et al., 2003; Sheng et al.,
2012). The alterations in goblet cell number and morphology in
Nod2/ mice are particularly striking, and defects in this cell
type are known to have devastating effects on barrier function
(Sheng et al., 2012). Also, our results demonstrating that these
goblet cell abnormalities are dependent on lymphocytes and
IFN-g are consistent with related findings in patients suggesting
that an excessive T cell response causes damage to the epithe-
lium (Abraham and Cho, 2009). These observations in a mouse
model are also consistent with the preferential association of
NOD2 mutation with small-intestinal involvement in humans
(Abraham and Cho, 2009). For this reason, we chose to demon-
strate the adverse effect ofB. vulgatus colonization by examining
the response of Nod2/ mice to piroxicam, a small-intestinal
injury model that is frequently used to investigate the relationship
betweenNSAID and recurrent IBD (Han et al., 2009). Notably, the
overgrowth of Bacteroides in Nod2/ mice under homeostatic
condition is masked by large-scale phylum-level changes after
piroxicam challenge. Although such shifts in microbial commu-
nities are consistent with observations made in CD patients (Ge-
vers et al., 2014), our results raise the possibility that expansion
of a bacterial species that initiated disease would no longer be
easily detectable once disease symptoms become apparent.
Hence, themajor shifts in composition that occur in an inflamma-
tory environment could make it difficult to identify specific proin-
flammatory bacteria in patients.
It will be critical in future studies to identify microbial factors
that regulate virulence in addition to investigating host pathways.
Bacteroides species are generally referred to as commensals
because they are ubiquitous members of the gut microbiota
and innocuous inmost settings (Wexler, 2007). Although the sus-
ceptibility of Nod2/ mice appears to be specific to a single
Bacteroides genus member, a limitation of our study is that we
examined only a subset of genus members. For instance, the
B. thetaiotomicron strain we used in this study has been shown
to colonize and evoke immune responses in mice but is originallya human isolate (Goodman et al., 2009; Hooper et al., 2001; Pe-
terson et al., 2007). Thus, the ability of a given Bacteroides strain
to induce abnormalities could require host-species-specific ad-
aptations. However, such microbial factors should not be inves-
tigated in isolation. Pioneering studies have demonstrated that
B. vulgatus induces colitis in germ-free HLA-B27 transgenic
rats but not in nontransgenic germ-free controls (Rath et al.,
1999). A more recent study showed that Bacteroides species
mediate disease in mice severely deficient in immune-regulatory
pathways (Il10r2/Tgfbr2DN mice) but not in cohoused controls
(Bloomet al., 2011). Similarly, we found that inoculation ofmetro-
nidazole-treated WT mice with B. vulgatus did not reproduce
intestinal abnormalities observed in Nod2/ mice despite a
similarly high degree of colonization during the time frame of
the experiment. This feature of B. vulgatus distinguishes it from
other members of the microbiota that can expand in a suscepti-
ble background and transfer disease toWT counterparts through
cohousing (Elinav et al., 2011; Garrett et al., 2007). Interestingly,
Nod2/ mice maintained at Jackson Laboratories are not
colonized by B. vulgatus (data not shown). Therefore, housing
conditions and animal facilities can clearly influence experi-
mental results between institutions. The complex epidemiology
of IBD in humans may reflect such variability in microbial expo-
sure. When taken together, our experiments support a multihit
model in which neither NOD2 mutation nor members of the
microbiota are sufficient to cause intestinal disease in isolation.
Finally, the susceptibility of Nod2/ mice to B. vulgatus
shares certain similarities with our previous findings with
Atg16L1 mutant mice and a specific strain of MNV (Cadwell
et al., 2010). In both cases, a specific gene-microbe interaction
leads to epithelial abnormalities in the intestine, and additional
inflammatory pathologies develop in response to chemical
injury. Thus, although the disease manifestation may be similar,
the precise combination of genetic and environmental factors
that initiate disease could vary considerably between individuals.
Future treatment options targeting early events in disease
progression may need to be personalized for patients to com-
plement strategies that target downstream manifestations of
inflammation such as TNF-a production.
EXPERIMENTAL PROCEDURES
Mice
Nod2/ mice backcrossed to the B6 background for at least 12 generations
were previously described (Kim et al., 2008). MyD88/ and Rag/ B6 mice
were fromJacksonLaboratoryandcrossed toNod2/mice togeneratedouble
mutants. Rip2/ and Atg16L1HM B6 mice were previously described (March-
iando et al., 2013). Unless stated otherwise, animals for experiments were pro-
duced by breedingmale and female mice homozygous for themutant allele in a
specific-pathogen-free (SPF) facility at NYU School of Medicine. WT B6 mice
were purchased from Jackson Laboratory and bred onsite to generate controls
for experiments. For cohousing experiments, two to threemice of one genotype
were placed in the same cage as two to three mice of the other genotype for at
least 2weeks prior to separation, atwhich point onlymice of the same genotype
were placed in the same cage. Bone marrow chimeras were generated by
lethally irradiating 8-week-old female recipient mice (1,100 CGy in two divided
doses) followed by i.v. injection of 5 3 106 T-cell-depleted bone marrow cells
from donor female mice. For anti-IFN-g treatment, mice were injected i.p. with
0.25 mg anti-IFN-g (clone H22) or isotype control (polyclonal hamster IgG)
(BioXCell) every 3 days for 9 days and animalswere sacrificed on day 10. All an-
imal studies were performed according to protocols approved by the NYU
School of Medicine Institutional Animal Care and Use Committee (IACUC).Immunity 41, 311–324, August 21, 2014 ª2014 Elsevier Inc. 321
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The Leica LMD6000 Laser Microdissection system was used to capture crypt
base epithelial cells from methacarn-fixed tissue as previously described
(Cadwell et al., 2008) and Arcturus PicoPure RNA isolation kit was used to
extract RNA. Enrichment of Paneth cells was confirmed by qPCR analysis of
a-defensin1 normalized to Gapdh relative to whole tissue scraped from the
paraffin-embedded section. The Ovation Pico WTA System V2 from NuGEN
was used to prepare and amplify cDNA, which was hybridized to a GeneChip
Mouse Gene ST array (Affymetrix). Pathway analysis of transcripts display-
ing >1.25-fold enrichment in Nod2/ samples was performed by Database
of Annotation, Visualization and Integrated Discovery (DAVID). Gene Set
Enrichment Analysis (GSEA) was used to compare results to the Molecular
Signatures Database (MSigDB).
Microscopy
Quantification of all microscopy data was performed blind. Intestinal sections
were prepared and stained with PAS-Alcian blue or H&E as previously
described (Cadwell et al., 2008, 2010). Goblet cells were quantified by count-
ing the total number per villi and graphed as individual values. IF analyses was
performed by staining formalin- or methacarn-fixed paraffin-embedded small
sections with anti-Reg3b (R&D Systems), anti-Relm-b (Peprotech), or anti-
Muc2 (Santa Cruz) followed by the appropriate secondary antibody. Sections
were imaged with the Zeiss 710 confocal microscope.
Isolation of IELs and LP Lymphocytes
Small intestine (Peyer’s patches removed) or colon was cut longitudinally and
rinsed in HBSS. The tissue was washed in HBSS containing HEPES, sodium
pyruvate, 5 mM EDTA, and 1 mM DTT for 15 min to obtain the IEL fraction.
The intestines were further washed in HBSS containing HEPES, sodium pyru-
vate, and EDTA and digested for 20 min using Collagenase VIII (Sigma) to
obtain the LP fraction. Both IEL and LP fractions were filtered and fractionated
on a Percoll gradient (40%and 80%). The cells at the interphase of the gradient
were collected and washed twice with complete RPMI.
Bacterial Culture and Inoculation
Fecal bacteria were quantified by dilution plating on selective BBE agar (BD) in
an anaerobic chamber (AS-580, Anaerobe Systems) at 37C. Colonies of a
single color and morphology grew from Nod2/ samples within 24–36 hr
but not WT samples. A total of 20 colonies from 3 Nod2/ samples were cho-
sen at random to identify the bacterium by sequencing of the 16S rRNA gene
(forward primer 1, 50-AGAGTTTGATCCTGGCTCAGGAT-30; reverse primer 1,
50-TCCTTTGAGTTTCACCGTTGCC-30; forward primer 2, 50-CAGGATTAGA
TACCCTGGTAGTCCA-30; reverse primer 2, 50-GACTTAGCCCCAGTCAC
CAGT-30). 100% of the sequenced colonies were identified as B. vulgatus.
For inoculation into mice, B. vulgatus was anaerobically cultured in PYG broth
at 37C for 48 hr and metronidazole-treated mice were gavaged with 1 3 108
bacteria. Metronidazole was lifted 24 hr prior to inoculation. Heat-killed
B. vulgatus was prepared by heating the culture at 80C in aerobic conditions
for 1 hr.B. thetaiotaomicron (VPI-5482) and B. uniformis (Eggerth and Gagnon)
were kindly provided by E. Martens and were cultured and administered to
mice using a similar procedure.
Administration of Antibiotics and Piroxicam
Mice were given 1 g/l metronidazole alone, 500 mg/l vancomycin alone, or in
combination with 1 g/l ampicillin and 1 g/l neomycin sulfate with 1% sucrose
(Sigma Aldrich) in their drinking water for 10 days. Stool from treated mice
was plated on blood agar and BBE agar to confirm reduction in total bacteria
or B. vulgatus, respectively. WT andNod2/mice were treated with 60mg/kg
piroxicam and 80 mg/kg piroxicam in powdered mouse chow for 7 days each.
For piroxicam experiments, mice received metronidazole for 10 days and after
reduction ofB. vulgatuswas confirmed, metronidazole was removed andmice
were treatedwith the two doses of piroxicam. A separate group ofmice treated
withmetronidazole were gavaged with 108 cfuB. vulgatus and treated with pir-
oxicam concurrently. H&E-stained small-intestinal sections of mice treated
with piroxicam were used for histopathological scoring in a blinded fashion.
Each mouse was given an individual cumulative score (max = 5) based on
the following criteria: number of focal ulcers (0, none; 0.5, one or two; 1, three
or more), extent of epithelial hyperplasia (0, none; 0.5, elongated villi and322 Immunity 41, 311–324, August 21, 2014 ª2014 Elsevier Inc.crypts; 1, severe hyperplasia where the crypt villus axis is two times higher
than the crypt villus axis in untreated mice), presence of immune infiltrates
(0, none; 0.5, pericryptal infiltrates; 1, submucosal infiltrates), presence of in-
testinal bleeding (1), and attachment of the intestine to the peritoneal cavity (1).
Statistical Analysis
Analyses except for microarray data used GraphPad Prism v.6. An unpaired
two-tailed t test was used to evaluate differences between two groups. An
ANOVA with the Holm-Sidak multiple comparisons test was used to evaluate
experiments involving multiple groups. For experiments requiring nonpara-
metric analyses, the Wilcoxon-Mann-Whitney test or Kruskal-Wallis with
Dunn’s multiple comparisons test were used.
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